Please Wait a Moment
X

CTS History

08Aug

CTS Business Continuity Plan

O'Dina Hurlburt |08 Aug, 2019 | Return|

About the Author

Related

Source Plasma / Blood Donor Testing

Source Plasma / Blood Donor Testing

In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).

Read More >
Disaster Reliability via Merged Information Systems

Disaster Reliability via Merged Information Systems

In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...

Read More >
CTS implements licensesd Zika test

CTS implements licensesd Zika test

Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...

Read More >
Babesia

Babesia

In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...

Read More >
Dengue Testing

Dengue Testing

CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.

Read More >